Clinical Trial Update: Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hepatic arterial idarubicin with lipiodol emulsion for hepatocellular carcinoma in cirrhosis; the study (NCT03727633) has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Idarubicin (idarubicin)
• Lipiodol Emulsion (lipiodol emulsion)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: TERMINATED